Contrast‐enhanced power Doppler sonography and helical computed tomography for assessment of vascularity of small hepatocellular carcinomas before and after percutaneous ablation
- 19 February 2003
- journal article
- research article
- Published by Wiley in Journal of Clinical Ultrasound
- Vol. 31 (3) , 119-128
- https://doi.org/10.1002/jcu.10151
Abstract
Purpose: We compared the usefulness of Levovist‐enhanced power Doppler imaging (PDI) and helical CT in the depiction of tumor vascularity before and after percutaneous ablation of small hepatocellular carcinomas (HCCs).Methods: Thirty‐one cirrhotic patients with solitary unresectable HCCs smaller than 5 cm (mean size, 2.7 ± 0.8 cm; range, 1.5–5.0 cm) recruited over a 15‐month period were treated with percutaneous ethanol injection (n = 9) or radiofrequency ablation (n = 22). PDI, contrast‐enhanced PDI (using Levovist), and multiphase contrast‐enhanced helical CT were performed before and after percutaneous ablation, and vascularity findings were compared.Results: Levovist significantly increased baseline intratumoral Doppler signals on PDI compared to non‐contrast PDI. The most frequent tumor vascularity pattern was heterogeneous (45%). Vascularity was identified in all tumors by both contrast‐enhanced PDI and helical CT before ablation. After percutaneous ablation, intratumoral vascularity was detected in 11 tumors by contrast‐enhanced PDI and in 15 tumors by CT. The sensitivity, specificity, and diagnostic accuracy of contrast‐enhanced PDI in demonstrating intratumoral vascularity, with CT being the gold standard, were 66%, 93%, and 81%, respectively. There was significant agreement between the 2 modalities in the depiction of tumor vascularity after ablation (κ = 0.6, p = 0.001). However, there were 5 false negatives and 1 false positive with contrast‐enhanced PDI. Complete tumor necrosis was achieved in 21 patients (68%).Conclusions: There was a good concordance between contrast‐enhanced PDI and helical CT in the depiction of HCC vascularity before and after percutaneous ablation. However, although contrast‐enhanced PDI may be useful for real‐time guidance of treatment, its low sensitivity makes it inadequate to accurately assess the completeness of ablation. © 2003 Wiley Periodicals, Inc. J Clin Ultrasound 31:119–128, 2003Keywords
Funding Information
- Programa “Ramon Cajal,” Ministerio de Ciencia y Tecnología (to J.M. Llovet)
This publication has 30 references indexed in Scilit:
- Prognostic prediction and treatment strategy in hepatocellular carcinomaHepatology, 2002
- Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL ConferenceJournal of Hepatology, 2001
- Contrast-Enhanced Subtraction Harmonic Sonography for Evaluating Treatment Response in Patients with Hepatocellular CarcinomaAmerican Journal of Roentgenology, 2001
- Power Doppler SonographyAmerican Journal of Roentgenology, 2000
- Prognosis of Hepatocellular Carcinoma: The BCLC Staging ClassificationSeminars in Liver Disease, 1999
- Epidemiology of Primary Liver CancerSeminars in Liver Disease, 1999
- Tissue harmonic imaging sonography: evaluation of image quality compared with conventional sonography.American Journal of Roentgenology, 1998
- Color Doppler ultrasound of liver lesions: Signal enhancement after intravenous injection of the ultrasound contrast agent Levovist®Journal of Clinical Ultrasound, 1996
- Tumor Size Determines the Efficacy of Percutaneous Ethanol Injection for the Treatment of Small Hepatocellular CarcinomaHepatology, 1992
- Sonography with intraarterial infusion of carbon dioxide microbubbles (sonographic angiography): value in differential diagnosis of hepatic tumors.American Journal of Roentgenology, 1992